SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-128350
Filing Date
2016-06-20
Accepted
2016-06-20 17:00:59
Documents
6
Period of Report
2016-06-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-13610_18k.htm 8-K 48489
2 EX-3.1 a16-13610_1ex3d1.htm EX-3.1 122735
3 EX-4.1 a16-13610_1ex4d1.htm EX-4.1 858713
4 EX-10.1 a16-13610_1ex10d1.htm EX-10.1 269622
5 EX-99.1 a16-13610_1ex99d1.htm EX-99.1 13230
6 GRAPHIC g136101mmi001.jpg GRAPHIC 2693
  Complete submission text file 0001104659-16-128350.txt   1318025
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 161722682
SIC: 2834 Pharmaceutical Preparations